| Pro-caspase-3 is a major physiologic target of caspase-8 HR Stennicke, JM Jurgensmeier, H Shin, Q Deveraux, BB Wolf, X Yang, ... Journal of Biological Chemistry 273 (42), 27084-27090, 1998 | 1025 | 1998 |
| Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance E Devarajan, AA Sahin, JS Chen, RR Krishnamurthy, N Aggarwal, ... Oncogene 21 (57), 8843-8851, 2002 | 561 | 2002 |
| Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin-and etoposide-induced apoptosis XH Yang, TL Sladek, X Liu, BR Butler, CJ Froelich, AD Thor Cancer research 61 (1), 348-354, 2001 | 400 | 2001 |
| Survival signaling by Notch1: mammalian target of rapamycin (mTOR)–dependent inhibition of p53 SK Mungamuri, XH Yang, AD Thor, K Somasundaram Cancer research 66 (9), 4715-4724, 2006 | 333 | 2006 |
| Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-i receptor in breast cancer cells resistant to herceptin X Huang, L Gao, S Wang, JL McManaman, AD Thor, XH Yang, FJ Esteva, ... Cancer research 70 (3), 1204-1214, 2010 | 288 | 2010 |
| Granzyme B mimics apical caspases: description of a unified pathway for trans-activation of executioner caspase-3 and-7 X Yang, HR Stennicke, B Wang, DR Green, RU Jänicke, A Srinivasan, ... Journal of Biological Chemistry 273 (51), 34278-34283, 1998 | 270 | 1998 |
| Granule-mediated killing: pathways for granzyme B–initiated apoptosis RV Talanian, XH Yang, J Turbov, P Seth, T Ghayur, CA Casiano, K Orth, ... The Journal of experimental medicine 186 (8), 1323-1331, 1997 | 255 | 1997 |
| Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases CJ Froelich, VM Dixit, X Yang Immunology Today 19 (1), 30-36, 1998 | 216 | 1998 |
| Downregulation of erbB3 abrogates erbB2‐mediated tamoxifen resistance in breast cancer cells B Liu, D Ordonez‐Ercan, Z Fan, SM Edgerton, XH Yang, AD Thor International journal of cancer 120 (9), 1874-1882, 2007 | 177 | 2007 |
| Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions B Liu, Z Fan, SM Edgerton, XH Yang, SE Lind, AD Thor Cell Cycle 10 (17), 2959-2966, 2011 | 176 | 2011 |
| Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during β-lapachone-mediated apoptosis JJ Pink, S Wuerzberger-Davis, C Tagliarino, SM Planchon, XH Yang, ... Experimental cell research 255 (2), 144-155, 2000 | 171 | 2000 |
| Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells N Saini, X Yang Acta biochimica et biophysica Sinica 50 (2), 133-143, 2018 | 169 | 2018 |
| Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention B Liu, S Edgerton, X Yang, A Kim, D Ordonez-Ercan, T Mason, K Alvarez, ... Cancer Research 65 (3), 879-886, 2005 | 167 | 2005 |
| The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress M Louis, RR Rosato, L Brault, S Osbild, E Battaglia, XH Yang, S Grant, ... International journal of oncology 25 (6), 1701-1711, 2004 | 107 | 2004 |
| Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells S Yang, Q Zhou, X Yang Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1773 (6), 903-911, 2007 | 105 | 2007 |
| Overexpression of the E2F-1 transcription factor gene mediates cell transformation XH Yang, TL Sladek Gene Expression 4 (4-5), 195, 1995 | 95* | 1995 |
| Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models P Zhu, M Davis, AJ Blackwelder, N Bachman, B Liu, S Edgerton, ... Cancer prevention research 7 (2), 199-210, 2014 | 90 | 2014 |
| Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice XH Yang, SM Edgerton, SD Kosanke, TL Mason, KM Alvarez, N Liu, ... Cancer research 63 (10), 2425-2433, 2003 | 82 | 2003 |
| The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells J Huang, S Wang, H Lyu, B Cai, XH Yang, J Wang, B Liu Molecular cancer 12, 1-15, 2013 | 80 | 2013 |
| p53 is required for metformin-induced growth inhibition, senescence and apoptosis in breast cancer cells P Li, M Zhao, AB Parris, X Feng, X Yang Biochemical and biophysical research communications 464 (4), 1267-1274, 2015 | 74 | 2015 |
